Pioneering and controversial geneticist who was one of the first to sequence the human genome, in part by using his own DNA ...
U.S. Genomic Medicine Market was valued at USD 9.93 billion in 2025 and is expected to reach USD 32.9 billion by 2035 owing to the increasing use of personalized medicineAustin, May 14, 2026 (GLOBE ...
ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of ...
Parasitologist and director of the Wellcome Trust who oversaw the launch of the UK’s flagship genome sequencing centre ...
By attempting to commercialise parts of the human genome, he sped up the development of gene sequencing technologies ...
Venous thromboembolism (VTE) is a disorder due to the interaction between genetic, individually acquired and environmental factors. The aim of this narrative review is to summarize advances in genetic ...
Researchers have developed a powerful new tool that can track how microbes spread between people with unprecedented precision, offering new ways to prevent infections and improve treatments based on ...
Craig Venter has died aged 79. He was at the forefront of sequencing the human genome and of synthetic biology, but divided opinion in how he went about it ...
Venter and his teams achieved a milestone by constructing the first self-replicating bacterial cell controlled by a chemically synthesized genome. American scientist Craig Venter, a global pioneer in ...
Aman Sanger is emerging as one of the key Indian-origin figures in the global artificial intelligence boom. A co-founder of Cursor, he is part of the team behind one of the fastest-growing AI coding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results